I am excited to announce that the original founding team of the award-winning speech, language, and cognitive app, Constant Therapy, is returning to the helm and launching a brand new digital therapeutics company, Constant Therapy Health, having acquired its existing suite of therapy apps.
With the COVID-19 public health emergency upending life as we know it, there is a growing need for quality telehealth solutions that maximize access to care while minimizing exposure. Our work to provide personalized therapy to patients anytime, anywhere is more important than ever before.
As we launch Constant Therapy Health, we will be building upon our original platform and it’s patented AI technology, The NeuroPerformance Engine™, to enable unprecedented access to speech, language and cognitive therapy. We’ve also broken ground on a first-of-its-kind telehealth solution that will enable clinicians to meet with patients virtually, and deliver therapy and monitor progress remotely.
Building upon our FDA breakthrough designation in 2020, we will continue to gather and analyze clinical evidence. We will also be kicking off a new collaboration with the world’s leading scientists and researchers to begin work on analyzing our dataset of 140 Million cognitive-linguistic therapy exercises to better understand brain rehabilitation.
In these times of uncertainty, we see unprecedented ingenuity that elevates us all. The COVID-19 pandemic has brought waves of telehealth policy expansions that desperately need to be filled with reliable, evidence-based solutions that work. As the original founders of an award-winning digital therapeutic, we’ve developed a solution that we know works, and has already helped thousands in their recovery journey. We look forward to working towards achieving our mission of improving access to care for those who need it most.
Visit www.constanttherapy.com to learn more or partner with us.
